Moreover, Mef2c played double-edged roles in hepatocellular carcinoma, which could mediate VEGF-induced malignancy enhancement and also inhibit hepatoma carcinoma cells proliferation through blockade of Wnt/β-catenin signaling [48]. The gene discussed is MEF2C; the disease is hepatocellular carcinoma.